On Tuesday, March 17th, Brent Saunders, CEO and President, appeared on the popular CNBC business television program Mad Money with Jim Cramer. In the feature interview, Brent discussed the strengths of our now combined Company, including our world-class product portfolio and commitment to R&D, and our future as a leading Growth Pharma Company.